{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:19:26Z","timestamp":1794899966173,"version":"4.9.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:p>Coronary slow flow phenomenon (CSFP) is characterized by slow coronary blood flow in the absence of significant stenosis, and its pathophysiology is associated with endothelial dysfunction, microvascular abnormalities, and inflammation. This study aimed to investigate the effects of statin therapy on subclinical inflammatory markers in CSFP patients. This retrospective cohort study included patients diagnosed with CSFP by using coronary angiography. The patients were divided into statin and control groups based on the initiation of statin therapy. Inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and systemic inflammation response index (SIRI) were assessed at baseline and 3 months later. At baseline, NLR, PLR, SII, and SIRI levels were comparable between the 2 groups. After 3 months, these markers were significantly lower in the statin group. In the statin group, the NLR, PLR, SII, and SIRI levels significantly decreased from baseline, whereas no significant changes were observed in the control group. The reduction in inflammatory marker levels was more pronounced in patients receiving high-dose statins. Statin therapy is associated with reduced subclinical inflammation in CSFP, supporting the inflammatory basis and therapeutic value of statins.<\/jats:p>","DOI":"10.1097\/md.0000000000043940","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:01:58Z","timestamp":1755198118000},"page":"e43940","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["The role of statins in modulating subclinical inflammatory markers in coronary slow flow phenomenon"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8835-9557","authenticated-orcid":false,"given":"Murat","family":"Demirci","sequence":"first","affiliation":[{"name":"Department of Cardiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0684-8231","authenticated-orcid":false,"given":"Urfan","family":"Mustafayev","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3423-509X","authenticated-orcid":false,"given":"Halil","family":"Ata\u015f","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5165-1212","authenticated-orcid":false,"given":"Mustafa","family":"O\u011fuz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Health Science University, Sultan 2. Abdulhamid Han Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8338-4948","authenticated-orcid":false,"given":"Raif","family":"Kili\u00e7","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mardin Artuklu University Faculty of Medicine, Mardin, Turkey."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7755-3370","authenticated-orcid":false,"given":"Murat","family":"S\u00fcnb\u00fcl","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Marmara University Pendik Training and Research Hospital, Istanbul, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1177\/00033197211004390","article-title":"Slow coronary flow: pathophysiology, clinical implications, and therapeutic management.","volume":"72","author":"Chalikias","year":"2021","journal-title":"Angiology"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tcm.2022.12.001","article-title":"Understanding the pathogenesis of coronary slow flow: recent advances.","volume":"34","author":"Zhu","year":"2024","journal-title":"Trends Cardiovasc Med"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"e08","DOI":"10.15420\/ecr.2021.46","article-title":"Slow coronary blood flow: pathogenesis and clinical implications.","volume":"17","author":"Aparicio","year":"2022","journal-title":"Eur Cardiol"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jcin.2024.02.025","article-title":"Angiographic coronary slow flow is not a valid surrogate for invasively diagnosed coronary microvascular dysfunction.","volume":"17","author":"Mayer","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1177\/1076029613498814","article-title":"Relationship between neutrophil to lymphocyte ratio and slow coronary flow.","volume":"21","author":"Do\u011fan","year":"2015","journal-title":"Clin Appl Thromb Hemost"},{"key":"R6-20261117","first-page":"307","article-title":"Predictive value of neutrophil lymphocyte ratio and platelet lymphocyte ratio in patients with coronary slow flow.","volume":"32","author":"\u00c7etin","year":"2016","journal-title":"Acta Cardiol Sin"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/0003319715574625","article-title":"Increased platelet to lymphocyte ratio is related to slow coronary flow.","volume":"67","author":"Akboga","year":"2016","journal-title":"Angiology"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5152\/akd.2014.5376","article-title":"Relationship between platelet-to-lymphocyte ratio and coronary slow flow.","volume":"15","author":"Oylumlu","year":"2015","journal-title":"Anatol J Cardiol"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1186\/s12872-022-02798-0","article-title":"Relationship between increased systemic immune-inflammation index and coronary slow flow phenomenon.","volume":"22","author":"Dai","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"R10-20261117","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.2147\/IJGM.S481538","article-title":"Association between systemic inflammation response index and slow coronary flow phenomenon in patients with ischemia and no obstructive coronary arteries.","volume":"17","author":"Chen","year":"2024","journal-title":"Int J Gen Med"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1136\/hrt.2005.082560","article-title":"Short-term statin treatment improves endothelial function and neurohormonal imbalance in normocholesterolaemic patients with non-ischaemic heart failure.","volume":"92","author":"Strey","year":"2006","journal-title":"Heart"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"105735","DOI":"10.1016\/j.biocel.2020.105735","article-title":"Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms.","volume":"122","author":"Liberale","year":"2020","journal-title":"Int J Biochem Cell Biol"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow.","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s11883-003-0008-z","article-title":"Isoprenoid metabolism and the pleiotropic effects of statins.","volume":"5","author":"Laufs","year":"2003","journal-title":"Curr Atheroscler Rep"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573403X13666170426104611","article-title":"The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature.","volume":"13","author":"Diamantis","year":"2017","journal-title":"Curr Cardiol Rev"},{"key":"R16-20261117","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2174\/138161212799504803","article-title":"Statins as anti-inflammatory agents in atherogenesis: molecular mechanisms and lessons from the recent clinical trials.","volume":"18","author":"Antonopoulos","year":"2012","journal-title":"Curr Pharm Des"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11883-021-00977-6","article-title":"Statins and inflammation.","volume":"23","author":"Satny","year":"2021","journal-title":"Curr Atheroscler Rep"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/clc.20140","article-title":"Effects of atorvastatin on coronary flow reserve in patients with slow coronary flow.","volume":"30","author":"Caliskan","year":"2007","journal-title":"Clin Cardiol"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"580419","DOI":"10.3389\/fcvm.2020.580419","article-title":"Effects of oral drugs on coronary microvascular function in patients without significant stenosis of epicardial coronary arteries: a systematic review and meta-analysis of coronary flow reserve.","volume":"7","author":"Yong","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1177\/0003319715604098","article-title":"Statin therapy may not effect NLR and MPV levels in patients with hypercholesterolemia: a retrospective study.","volume":"67","author":"Gungoren","year":"2016","journal-title":"Angiology"},{"key":"R21-20261117","doi-asserted-by":"crossref","first-page":"227","DOI":"10.21037\/atm-20-6710","article-title":"Systemic inflammation is associated with inferior disease control and survival in stage III non-small cell lung cancer.","volume":"9","author":"Keit","year":"2021","journal-title":"Ann Transl Med"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"e20230540","DOI":"10.36660\/abc.20230540","article-title":"The relationship between the systemic immune-inflammation index and ischemia with non-obstructive coronary arteries in patients undergoing coronary angiography.","volume":"121","author":"Karakayali","year":"2024","journal-title":"Arq Bras Cardiol"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1536\/ihj.50.545","article-title":"Efficacy of nebivolol on flow-mediated dilation in patients with slow coronary flow.","volume":"50","author":"Albayrak","year":"2009","journal-title":"Int Heart J"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.mehy.2006.09.070","article-title":"Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property.","volume":"69","author":"Li","year":"2007","journal-title":"Med Hypotheses"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.12902","article-title":"Immune modulatory effects of statins.","volume":"154","author":"Zeiser","year":"2018","journal-title":"Immunology"},{"key":"R26-20261117","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000109405","article-title":"Simvastatin may improve myocardial perfusion abnormality in slow coronary flow.","volume":"110","author":"Cakmak","year":"2008","journal-title":"Cardiology"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043940","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:00:20Z","timestamp":1794898820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":26,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043940","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}